Autologous dermal fibroblasts therapy (S.Biomedics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAutologous dermal fibroblasts therapy (S.Biomedics)

Drug Alias NameCureskin

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Somatic cell > Dermal fibroblasts therapy

Mechanisms of ActionUpdating

TargetsNot applicable

Therapy Area/IndicationsCicatrix

Global Approved IndicationsCicatrix

Approved Indications in ChinaN/A

Original Approved Country/TerritorySouth Korea

Original Approved Date2010/11/01

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesS.Biomedics Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesS.Biomedics Co Ltd

Inactive CompaniesN/A

Active IndicationsCicatrix

Inactive IndicationsN/A

Other Information

ATC CodeV03AX